Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

In Like a Lamb; Out Like a Lion: Marching CAR T Cells Toward Enhanced Efficacy in B-ALL

Mol Cancer Ther (2021) 20 (7): 1223–1233.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Humanization of the antigen-recognition domain does not impinge on the antigen-binding, cytokine secretion, and antitumor reactivity of humanized nanobody-based CD19-redirected CAR-T cells
  • Pooria Safarzadeh Kozani
  • Pouya Safarzadeh Kozani
  • Fatemeh Rahbarizadeh
Journal of Translational Medicine (2024) 22 (1)
Challenges and innovations in CAR-T cell therapy: a comprehensive analysis
  • Jingming Luo
  • Xianwen Zhang
Frontiers in Oncology (2024) 14
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy
  • Xueyan Chen
  • Qi Gao
  • Mikhail Roshal
  • Sindhu Cherian
Cytometry Part B: Clinical Cytometry (2023) 104 (3): 205.
Difference in Efficacy and Safety of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Containing 4-1BB and CD28 Co-Stimulatory Domains for B-Cell Acute Lymphoblastic Leukemia
  • Lijuan Wu
  • Junchao Chen
  • Ruifen Cai
  • Xinrui Wang
  • Yixiao Liu
  • Qingshan Zheng
  • Lujin Li
Cancers (2023) 15 (10): 2767.
Cmpd10357 to treat B-cell acute lymphoblastic leukemia
  • Alex Q. Lee
  • Hiroaki Konishi
  • Elizabeth Helmke
  • Masami Ijiri
  • Jan Michael A. Lerot
  • Emma Hicks
  • Jeremy R. Chien
  • Fredric A. Gorin
  • Noriko Satake
Experimental Hematology (2023) 119-120: 8.
T-cells engineered with a novel VHH-based chimeric antigen receptor against CD19 exhibit comparable tumoricidal efficacy to their FMC63-based counterparts
  • Fatemeh Nasiri
  • Pooria Safarzadeh Kozani
  • Fatemeh Rahbarizadeh
Frontiers in Immunology (2023) 14
Are we there yet? cellular therapies for cutaneous T cell lymphoma
  • Pinar Ataca Atilla
  • Erden Atilla
Current Research in Translational Medicine (2023) 71 (2): 103390.
Characterization of novel CD19-specific VHHs isolated from a camelid immune library by phage display
  • Mahmoud Ganji
  • Pooria Safarzadeh Kozani
  • Fatemeh Rahbarizadeh
Journal of Translational Medicine (2023) 21 (1)
CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer
  • Fatemeh Nasiri
  • Khadijeh Farrokhi
  • Pouya Safarzadeh Kozani
  • Maral Mahboubi Kancha
  • Setareh Dashti Shokoohi
  • Pooria Safarzadeh Kozani
Frontiers in Immunology (2023) 14
Chimeric antigen receptor T cells therapy in solid tumors
  • Fatimah Rababah
  • Taqwa Alabduh
  • AlHareth Awawdeh
  • Tareq Shatnawi
  • Maha AL-shdaifat
  • Elana Ibdah
  • Shatha Shatnawi
  • Yahia AbuZetun
  • Ahmed Mohamed Helaly
  • Doaa S. Ghorab
Clinical and Translational Oncology (2023) 25 (8): 2279.
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
  • Hamed Dabiri
  • Pooria Safarzadeh Kozani
  • Mahdi Habibi Anbouhi
  • Mohadeseh Mirzaee Godarzee
  • Mohammad Hossein Haddadi
  • Mohsen Basiri
  • Vahab Ziaei
  • Majid Sadeghizadeh
  • Ensiyeh Hajizadeh Saffar
Biomarker Research (2023) 11 (1)
Effectiveness and safety of anti-BCMA chimeric antigen receptor T-cell treatment in relapsed/refractory multiple myeloma: a comprehensive review and meta-analysis of prospective clinical trials
  • Dingyuan Hu
  • Liming Chen
  • Diqin Yan
  • Wenliang Dong
  • Min Chen
  • Suping Niu
  • Simin Wang
  • Jiaojiao Zhang
  • Xiaoyan Nie
  • Yi Fang
Frontiers in Pharmacology (2023) 14
Metabolic and epigenetic orchestration of (CAR) T cell fate and function
  • Behnia Akbari
  • Zahra Hosseini
  • Pardis Shahabinejad
  • Saba Ghassemi
  • Hamid Reza Mirzaei
  • Roddy S. O'Connor
Cancer Letters (2022) 550: 215948.
CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?
  • Pooria Safarzadeh Kozani
  • Pouya Safarzadeh Kozani
  • Fatemeh Rahbarizadeh
Frontiers of Medicine (2022) 16 (3): 322.
Effects of polybrene and retronectin as transduction enhancers on the development and phenotypic characteristics of VHH-based CD19-redirected CAR T cells: a comparative investigation
  • Fatemeh Nasiri
  • Samad Muhammadnejad
  • Fatemeh Rahbarizadeh
Clinical and Experimental Medicine (2022) 23 (6): 2535.
Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies
  • Danni Xie
  • Xin Jin
  • Rui Sun
  • Meng Zhang
  • Jiaxi Wang
  • Xia Xiong
  • Xiaomei Zhang
  • Mingfeng Zhao
Technology in Cancer Research & Treatment (2022) 21: 153303382211184.
Nanobody-based CAR-T cells for cancer immunotherapy
  • Pouya Safarzadeh Kozani
  • Abdolhossein Naseri
  • Seyed Mohamad Javad Mirarefin
  • Faeze Salem
  • Mojtaba Nikbakht
  • Sahar Evazi Bakhshi
  • Pooria Safarzadeh Kozani
Biomarker Research (2022) 10 (1)
Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?
  • Pouya Safarzadeh Kozani
  • Pooria Safarzadeh Kozani
  • Milad Ahmadi Najafabadi
  • Fatemeh Yousefi
  • Seyed Mohamad Javad Mirarefin
  • Fatemeh Rahbarizadeh
Frontiers in Immunology (2022) 13
Progress on CAR-T cell therapy for hematological malignancies
  • Kejia HU
  • Yue HUANG
  • Yongxian HU
  • He HUANG
Journal of Zhejiang University (Medical Sciences) (2022) 51 (2): 192.
CRISPR/Cas9-medaited knockout of endogenous T-cell receptor in Jurkat cells and generation of NY-ESO-1-specific T cells: An in vitro study
  • Pouya Safarzadeh Kozani
  • Mohammad Ali Shokrgozar
  • Mehdi Evazalipour
  • Mehryar Habibi Roudkenar
International Immunopharmacology (2022) 110: 109055.
Addressing the obstacles of CAR T cell migration in solid tumors: wishing a heavy traffic
  • Pooria Safarzadeh Kozani
  • Pouya Safarzadeh Kozani
  • Fatemeh Rahbarizadeh
Critical Reviews in Biotechnology (2022) 42 (7): 1079.
CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?
  • Pouya Safarzadeh Kozani
  • Pooria Safarzadeh Kozani
  • Fatemeh Rahbarizadeh
Stem Cell Research & Therapy (2021) 12 (1)
In Silico Designing of a Novel Antibody Conjugate as a Potential Immunotherapeutic for the Treatment of CD19-Positive Hematologic Malignancies
  • Pooria Safarzadeh Kozani
Trends in Medical Sciences (2021) 1 (2)
Cell therapy products are revolutionizing multiple therapeutic areas; to maintain this pace of innovation, manufacturing solutions must adapt
  • Eytan Abraham
  • Nuala Trainor
  • Nicholas Ostrout
  • Matthew M. Hewitt
Current Opinion in Biomedical Engineering (2021) 20: 100340.
Promoting the Effector Function of Natural Killer (NK) Cells with a Focus on Bispecific Redirecting Antibodies
  • Pouya Safarzadeh Kozani
  • Pooria Safarzadeh Kozani
  • Abdolkarim Sheikhi
Trends in Medical Sciences (2021) 1 (3)
Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
  • Pouya Safarzadeh Kozani
  • Pooria Safarzadeh Kozani
  • Fatemeh Rahbarizadeh
Frontiers in Immunology (2021) 12
Adverse Events and Side Effects of Chimeric Antigen Receptor (CAR) T Cell Therapy in Patients with Hematologic Malignancies
  • Pooria Safarzadeh Kozani
  • Shima Shabani
Trends in Medical Sciences (2021) 1 (1)
Monoclonal Antibodies (mAbs) Approved for Cancer Treatment in the 2020s
  • Pouya Safarzadeh Kozani
  • Abdolhossein Naseri
  • Pooria Safarzadeh Kozani
  • Sanaz Khatami
  • Abdolkarim Sheikhi
Trends in Medical Sciences (2021) 1 (2)
  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept